Filip K. Knop
Center for Clinical Metabolic Research, Gentofte Hospital, Denmark · Department of Clinical Medicine, University of Copenhagen, Gentofte Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Filip K. Knop as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:27 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06419686 · The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy IndividualsUniversity Hospital, Gentofte, Copenhagen · unknown · Effect of iv Administration of GIP and Alanine
- N/ANCT06254365 · Investigating Glucose Metabolism of LEAP2 With Total-body PET/CTUniversity Hospital, Gentofte, Copenhagen · active not recruiting · Obesity
- N/ANCT06186063 · The Role of Amylin in Bone MetabolismFilip Krag Knop · unknown · Bone Diseases, Metabolic, Type 1 Diabetes · principal investigator
- Ph2NCT05788601 · Dapiglutide for the Treatment of ObesityUniversity Hospital, Gentofte, Copenhagen · active not recruiting · Obesity, Inflammation
- N/ANCT05056584 · The Role of the Kidneys and Liver in the Elimination of GlucagonUniversity Hospital, Gentofte, Copenhagen · completed · Chronic Kidney Diseases, Liver Cirrhosis, Hyperglucagonemia
- Early Ph1NCT04897984 · LEAP2 Kinetics in Healthy IndividualsUniversity Hospital, Gentofte, Copenhagen · completed · Obesity
- Ph2NCT04836273 · Treatment of Post-bariatric HypoglycaemiaFilip Krag Knop · completed · Hyperinsulinemic Hypoglycemia, Postprandial Hypoglycemia
- Early Ph1NCT04621409 · LEAP2 on Postprandial Glucose Metabolism and Food IntakeUniversity Hospital, Gentofte, Copenhagen · completed · Obesity
- N/ANCT04613700 · The Role of Secretin on the Energy HomeostasisSteno Diabetes Center Copenhagen · completed · Obesity, Metabolic Disease, Diabetes
- N/ANCT04351581 · Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19University Hospital, Gentofte, Copenhagen · completed · Covid-19
- N/ANCT04315350 · The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin ResistanceUniversity Hospital, Gentofte, Copenhagen · terminated · Insulin Resistance, Non-Alcoholic Fatty Liver Disease
- N/ANCT04229550 · Metabolic Effects of One-weak Heavy DrinkingUniversity Hospital, Gentofte, Copenhagen · completed · Metabolic Disturbance, Alcohol; Harmful Use, Glucose Intolerance
- N/ANCT04228484 · The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 DiabetesUniversity Hospital, Gentofte, Copenhagen · completed · Type2 Diabetes
- N/ANCT04043585 · Bariatric Surgery on NASHUniversity Hospital, Gentofte, Copenhagen · completed · Non-Alcoholic Fatty Liver Disease, Obesity
- Early Ph1NCT04043065 · Liver-enriched Antimicrobial Peptide 2University Hospital, Gentofte, Copenhagen · completed · Type 2 Diabetes
- Ph4NCT03955575 · Treatment of Bile Acid Malabsorption With LiraglutideFilip Krag Knop · completed · Bile Acid Malabsorption
- N/ANCT03892369 · FGF21 and Its Role in Alcohol DependenceUniversity Hospital, Gentofte, Copenhagen · completed · Alcohol Abuse or Dependence
- N/ANCT03739268 · GLP-1-mediated Gluco-metabolic Effects of Bile Acid SequestrationSteno Diabetes Center Copenhagen · completed · Type 2 Diabetes Mellitus
- Early Ph1NCT03682172 · Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male SubjectsSteno Diabetes Center Copenhagen · completed · Effect of Glucagon-like Peptide 2 on Gallbladder Motility
- N/ANCT03556098 · Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 DiabetesSteno Diabetes Center Copenhagen · completed · Diabetes Mellitus, Type 1
- N/ANCT03389269 · Investigation of Acute Physiological Effects of Aspiration TherapyUniversity Hospital, Gentofte, Copenhagen · completed · Obesity, Weight Loss
- N/ANCT03305783 · The Influence of Cholecystectomy on Secretion of Incretin HormonesUniversity Hospital, Gentofte, Copenhagen · completed · Glucose Metabolism Disorders
- N/ANCT03246451 · The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2DUniversity Hospital, Gentofte, Copenhagen · completed · Glucose Metabolism Disorders
- N/ANCT03241303 · Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small IntestinesUniversity Hospital, Gentofte, Copenhagen · completed · Glucose Metabolism Disorders
- N/ANCT03133741 · Inhibition of the Endogenous GIP Response With a GIP Receptor AntagonistUniversity Hospital, Gentofte, Copenhagen · completed · Glucose Metabolism Disorders
- N/ANCT03018444 · The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 SecretionUniversity Hospital, Gentofte, Copenhagen · completed · Diabetes Mellitus, Type 2, Hydroxymethylglutaryl-CoA Reductase Inhibitors · principal investigator
- N/ANCT03003793 · Insulin Sensitivity in Patients With Atopic DermatitisUniversity Hospital, Gentofte, Copenhagen · completed · Atopic Dermatitis/Eczema, Type 2 Diabetes
- N/ANCT02944110 · Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor AntagonismUniversity Hospital, Gentofte, Copenhagen · unknown · Diabetes After Total Pancreatectomy
- N/ANCT02747472 · GIP Receptor Antagonist Studies in HumansUniversity Hospital, Gentofte, Copenhagen · completed · Glucose Metabolism
- N/ANCT02640118 · The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised SubjectsUniversity Hospital, Gentofte, Copenhagen · completed · Diabetes After Total Pancreatectomy
- N/ANCT02360878 · The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin HormonesFilip Krag Knop · completed · Type 2 Diabetes, Obesity
- Ph4NCT02192853 · Correlation Between Plasma- and Endothelial DPP-4 ActivityUniversity Hospital, Gentofte, Copenhagen · completed · Type 2 Diabetes Mellitus
- N/ANCT01274052 · Study of Postprandial Incretin Response in Women With Gestational DiabetesUniversity Hospital, Gentofte, Copenhagen · completed · Gestational Diabetes Mellitus
- N/ANCT01173978 · Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose ToleranceGlostrup University Hospital, Copenhagen · completed · Insulin Resistance, Deteriorated Glucose Homeostasis, Inactivity
- Ph1/Ph2NCT01048268 · Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?University Hospital, Gentofte, Copenhagen · completed · Diabetes Mellitus
- N/ANCT01043445 · -Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.Glostrup University Hospital, Copenhagen · completed · Type 2 Diabetes
- N/ANCT00716170 · GIP, GLP-1 and GLP-2 in Type 2 Diabetic HyperglucagonemiaHerlev Hospital · completed · Type 2 Diabetes Mellitus
- N/ANCT00713440 · Incretin Physiology Associated With Steroid Hormone TreatmentGlostrup University Hospital, Copenhagen · completed · Type 2 Diabetes Mellitus, Steroids
- N/ANCT00704795 · Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 DiabetesUniversity Hospital, Gentofte, Copenhagen · unknown · Hyperglucagonemia, Hyperglycemia, Diabetes Mellitus
- N/ANCT00639613 · The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic HyperglucagonemiaUniversity Hospital, Gentofte, Copenhagen · completed · Type 2 Diabetes
- N/ANCT00638573 · The Incretin Effect in Patients With Chronic PancreatitisUniversity Hospital, Gentofte, Copenhagen · completed · Chronic Pancreatitis, Type 2 Diabetes Mellitus
- N/ANCT00625040 · Incretin Physiology and Beta-cell Function Before and After Weight-lossGlostrup University Hospital, Copenhagen · terminated · Obesity
- N/ANCT00529048 · Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 DiabetesHerlev Hospital · completed · Incretin Effect
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- F20OC008411RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT06254365
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:27 UTC. The ranking covers the 200 most relevant of 155 PubMed records, and a shared surname and initials can bring in a namesake. All 155 on PubMed
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.J Hepatol · 2014473 citationsRCR 15.6
- 365 citationsRCR 39.5
- Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.Diabetes · 2011303 citationsRCR 8.4
- 288 citationsRCR 33.0
- The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.J Clin Endocrinol Metab · 2003179 citationsRCR 4.2
- evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.Alzheimers Res Ther · 2025158 citationsRCR 47.2
- 156 citationsRCR 6.9
- Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.Lancet Diabetes Endocrinol · 2016152 citationsRCR 5.6
- The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty.Am J Physiol Gastrointest Liver Physiol · 2013150 citationsRCR 5.0
- Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.JCI Insight · 2018136 citationsRCR 5.5